Successful disruption of cancer gene | Dana-Farber Cancer Institute
2,536 views · Published 8 September 2011 · 3:39 · Indexed 25 October 2026
Channel: Dana-Farber Cancer Institute · 2011 · Education
James Bradner, MD, and Constantine Mitsiades, MD, explain their recent study to inhibit the improper activation of the regulatory protein MYC using the molecule JQ1 and what the findings could mean for patients with multiple myeloma. Read more: http://www.dana-farber.org/Newsroom/News-Releases/Novel-approach-scores-first-success-against-elusive-cancer-gene.aspx
More from this channel
-
0:18
Importance of Joining the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:20
How to Join the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:18
How to Register as a Stem Cell Donor | Dana-Farber Cancer Institute
-
3:03
Sportscaster Jim Britt for the Jimmy Fund | Dana-Farber Cancer Institute
-
0:07
Dana-Farber Banners | Dana-Farber Cancer Institute
-
2:08
Barbers for the Jimmy Fund | Dana-Farber Cancer Institute
-
1:43
Pets | Dana-Farber Cancer Institute
-
1:34
Healthy Eating for the Holiday Season | Dana-Farber Cancer Institute